Search Results 1701-1710 of 14736 for anti-TNF drugs

  1. Tofacitinib (Oral Route) Proper Use - Mayo Clinic

    This medicine should come with a Medication Guide. Read and follow the instructions carefully. Ask your doctor if you have any questions.

  2. Mirtazapine (Oral Route) Precautions - Mayo Clinic

    Some examples of CNS depressants are antihistamines or medicine for allergies or colds, sedatives, tranquilizers, or sleeping medicines, prescription pain ...

  3. Fluorouracil (Intravenous Route, Injection Route) Description and Brand Names - Mayo Clinic

    Fluorouracil belongs to the group of medicines known as antimetabolites. It is used to treat cancer of the colon, rectum, breast, stomach, and pancreas. It may ...

  4. Topotecan (Intravenous Route) Precautions - Mayo Clinic

    Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 3 months after the last dose. If ...

  5. Pillars and Programs - Center for Individualized Medicine - Mayo Clinic Research

    Additionally, this pillar investigates microorganisms with potential therapeutic benefits, validates strategies for gene therapy and analyzes biological age and ...

  6. Difluprednate (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    It is also used to treat an eye condition called endogenous anterior uveitis (eye inflammation). This medicine belongs to the group of medicines known as ...

  7. Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma - Mayo Clinic

    Further, these gains have been the result of interventions during the Consolidation (tandem autologous stem cell transplant) and Post-Consolidation (dinutuximab ...

  8. Study of RP-3500 With Niraparib or Olaparib in Advanced Solid Tumors - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... anti-tumor activity. Participation eligibility.

  9. A Study to Evaluate Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Patients - Mayo Clinic

    About this study. The purpose of this study is to evaluate, jointly and independently among patients deemed at higher risk vs. lower risk for disability ...

  10. Daratumumab And Hyaluronidase-Fihj (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Daratumumab And Hyaluronidase-Fihj (Subcutaneous Route) ... treatment) multiple myeloma in patients who have received at least 1 previous ...